Definition: Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
Input: "The story mentions that 30 capsules ofOSR#1 cost $60. It would have been nice had the story also includedinformation about the amount of active ingredient per capsuleand the manufacturer's recommendeddosage. This wouldhave allowed readers to make a better calculation as to the financial impact oftreatment. This is critical information consideringthese costs will be borne out of pocket by anyone usingOSR #1. The storyjuxtaposes a light-hearted""success story""with information about the industrial uses of OSR #1 for removing toxic heavy metals from contaminated soil. This is a clever way ofway of emphasizingthat the use of this product is based entirely on anecdote. The storyclearly states that there is no credible evidence supporting the efficacy of the product. The harms of this product are impossible to quantify, given that it doesn't seem to have been studied in humans or in animals. The story notes that otherchelating drugs carry ""significant risks""and ""can strip the body of metals necessary for health."" It would have been nice to see more specifics about what chelators can do, but the story satisfies the critierion. The story states that medical searches turned up no papers about OSR#1, and that the companywhich makesthe productprovided nopublished studies about its use. The story rightly suggests that this total lack of evidenceshould be deeply troubling. The story doesn't exaggerate the prevalence or severity of autism, or of the potentially toxic compounds sometimes used to treat it. The story quotes multiple experts on pharmacology and an FDA spokesperson. It also quotes from an interview with Boyd Haley, president of the company which makes OSR#1. It attempted to get a reaction from Kim Stagliano, an OSR #1 proponent, but this effort was not successful. While the story mentions that there other are chelation drugs out there, it could have mentioned that there areeducational strategies which can be helpful for children with autism and which have betterevidence to support their use. The story states that OSR#1 is, according to the manufacturer'swebsite, available onlythrough dentists' or doctors' offices. Itnotes, however,that theTribune was able to buy 30 capsules of the productdirectly from a compounding pharmacy listed on the site. We areimpressed that the Tribune went to these lengths toestablish the product's availability. The story provides a fairly detailedpedigree for OSR #1and discusses itssimilarity to other chelation therapiesused in the treatment of autism. It also gives credit to blogger Kathleen Seidel for being the first to raiseconcerns aboutOSR #1 in her blog, Neurodiversity.com The story is well sourced and is not based on a press release."
Output:
Industrial chemical OSR#1 used as autism treatment